Skip to content

Author

Berna Polat Tüysüz

We have 2 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Extended-Release Guanfacine Hydrochloride is Safe and Effective as Mono- and Adjunctive Therapy in Children and Adolescents with ADHD: A Naturalistic, Multi-Center, Patient-Reported Outcome Measures-Based Study.

AIMS Attention-deficit hyperactivity disorder (ADHD) is characterized by impairing and age-inappropriate inattention, hyperactivity, and impulsivity. Extended-release guanfacine hydrochloride (GXR) is a selective α2A-adrenergic agonist approved as mono- and adjunctive therapy to psychostimulant medications for ADHD. Th...

M. Kutuk, A. Tufan, Fethiye Kılıçaslan et al. · 0 citations
Review Open access Sep 2026

Clinical Use of Aripiprazole Monohydrate Long-Acting Injectable in Adolescents: A Case Series and Review of the Literature.

AM LAI appears to be a safe and effective off-label treatment option in high-risk adolescents with poor adherence to oral antipsychotics, and contributes clinically relevant real-world data to the limited literature on LAI use in pediatric psychiatry.

Fethiye Kılıçaslan, Harun Yardımcı, Berna Polat Tüysüz · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.